Abbott Laboratories (NYSE:ABT) is included among the 12 Most Profitable Dividend Stocks to Buy in 2026. Evercore ISI Says Abbott’s (ABT) Core Growth Drivers Are Still Intact Courtesy of Abbott Labs On January 23, Evercore ISI trimmed its price target on Abbott Laboratories (NYSE:ABT) to $138 from$144. However, it kept an Outperform rating. The firm acknowledged the recent stumbles that led to a quarterly miss and a more cautious outlook for the second half, but said the bigger picture has not changed. ...